In vitro, increased CCN2 mRNA expression or protein production was shown to result from the exposure of cultured Day 4 primary rat HSC to glucose or insulin to mimic, respectively, the hyperglycemia or insulin resistance that are frequently seen in NASH patients [51]. The gene discussed is CCN2; the disease is metabolic dysfunction-associated steatohepatitis.